Continuing Education for Nurses and Social Workers
GOAL
To educate oncology nurses and social workers about diagnosis & treatment of myelodysplastic syndromes (MDS)OBJECTIVES
At the conclusion of this program, participants should be able to:
- Define MDS
- Identify the diagnostic tests for MDS
- Explain the factors used to develop a plan for treatment
- Identify current and emerging therapies for MDS
- Describe possible treatment side effects and management to patients
- Communicate the role of clinical trials in the advancement of MDS treatment for patients
TARGET AUDIENCE
Oncology nurses and social workers involved in the treatment of MDSCERTIFICATION
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of registered nursing.The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: December 2011 – December 2014. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.0 CE clinical clock hour.
Upon completion of this program and submission of the CE activity evaluation, a certificate of completion will be issued to you via email or US mail within 30 days.
Be sure to forward this information to the patients and caregivers you serve so they and their families can also participate.